End of Period Subscribers of 4.0 million
Revenues of $214.9 million
Gross margin of 66.0%; excluding the net impact of restructuring charges, adjusted gross margin of 66.2%
Operating Income of $30.6 million; excluding the net impact of restructuring charges, adjusted operating income of $36.6 million
Full Year Fiscal 2023 Guidance Update:
- Revenues are expected to be at the low end of the previously provided range of $890.0 million to $910.0 million
- Operating Income is now expected to be in the range of $31.0 million to $43.0 million; excluding the net impact of restructuring charges and acquisition transaction costs, adjusted operating income is still expected to be towards the high end of the previously provided range of $80.0 million to $85.0 million

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") today announced its results for the third quarter of fiscal 2023.

"We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product," said Sima Sistani, the Company's CEO. "Clinical subscribers ended the quarter at 45 thousand, up 23% from Q2. We are encouraged by the trends across our business and we expect to end the year with total subscribers slightly above 3.7 million, representing the best seasonal slope in the Company's reporting history."

"We are executing well against our strategy and are on track for meeting, and in some cases exceeding, our 2023 objectives. As anticipated, the strategic decisions to promote long-term commitment plans and to wind down our low-margin consumer products business pressured revenues in the quarter. However, as demonstrated by our record gross margin, I am confident we are making the right decisions to return the business to profitable growth," said Heather Stark, the Company's CFO.

Q3 2023 Consolidated Results

								% Change Adjusted for Constant Currency⁽¹⁾
	Three Months Ended
	September 30,		October 1,
	2023		2022			% Change
(in millions except percentages and per share amounts)
Subscription Revenues, net	$	203.5	$	220.7		(7.8	%)	(9.2	%)
Product Sales and Other, net		11.4		29.0		(60.7	%)	(61.0	%)
Revenues, net	$	214.9	$	249.7		(14.0	%)	(15.3	%)
Gross Profit	$	141.8	$	152.4		(7.0	%)	(8.7	%)
Non-GAAP Adjustments⁽¹⁾
Net Restructuring Charges⁽²⁾		0.4		0.0
Adjusted Gross Profit⁽¹⁾	$	142.2	$	152.4		(6.7	%)	(8.5	%)
Operating Income (Loss)	$	30.6	($	254.5	)	112.0	%	111.4	%
Non-GAAP Adjustments⁽¹⁾
Franchise Rights Acquired Impairments		-		312.7
Net Restructuring Charges⁽²⁾		6.0		3.7
Adjusted Operating Income⁽¹⁾	$	36.6	$	61.9		(40.9	%)	(43.5	%)
Net Income (Loss)	$	43.7	($	206.0	)	100.0%*		100.0%*
EPS	$	0.54	($	2.93	)	100.0%*		100.0%*
Total Paid Weeks		52.5		51.9		1.0	%	N/A
Digital⁽³⁾ Paid Weeks		42.8		41.6		2.9	%	N/A
Workshops + Digital⁽⁴⁾ Paid Weeks		9.1		10.3		(11.6	%)	N/A
Clinical⁽⁵⁾Paid Weeks		0.5		-		N/A		N/A
End of Period Subscribers⁽⁶⁾		4.0		3.8		6.0	%	N/A
Digital Subscribers		3.3		3.0		7.8	%	N/A
Workshops + Digital Subscribers		0.7		0.7		(7.3	%)	N/A
Clinical Subscribers		0.0		-		N/A		N/A
___________________________________ Note: Totals may not sum due to rounding. *Note: Percentage in excess of 100.0% and not meaningful. ⁽¹⁾See "Reconciliation of Non-GAAP Financial Measures" attached to this release for further detail on adjustments to GAAP financial measures. ⁽²⁾See "Reconciliation of Non-GAAP Financial Measures" attached to this release for further detail on the Company's previously disclosed 2023, 2022, and 2021 restructuring plans, and the reversal of certain of the charges associated therewith. ⁽³⁾"Digital" refers to providing subscriptions to the Company's digital product offerings, which formerly included Digital 360 (as applicable). ⁽⁴⁾"Workshops + Digital" refers to providing unlimited access to the Company's workshops combined with the Company's digital subscription product offerings to commitment plan subscribers, including former Digital 360 members (as applicable). It also formerly included the provision of access to workshops for members who did not subscribe to commitment plans, which included the Company's "pay-as-you-go" members. ⁽⁵⁾"Clinical" refers to providing subscriptions to the Company's clinical product offerings included in its Sequence program. ⁽⁶⁾"Subscribers" refers to Digital subscribers, Workshops + Digital subscribers, and Clinical subscribers who participate in recurring bill programs in Company-owned operations.

Q3 2023 Business and Financial Highlights

End of Period Subscribers in Q3 2023 were up 6.0% versus the prior year period, driven by the Digital business and the inclusion of 45 thousand Clinical Subscribers. Q3 2023 End of Period Digital Subscribers increased 7.8% versus the prior year period. Q3 2023 End of Period Workshops + Digital Subscribers decreased 7.3% versus the prior year period.
Total Paid Weeks in Q3 2023 were up 1.0% versus the prior year period, driven by the Digital business in North America and the inclusion of 534 thousand Clinical Paid Weeks. Q3 2023 Digital Paid Weeks increased 2.9% versus the prior year period. Q3 2023 Workshops + Digital Paid Weeks decreased 11.6% versus the prior year period.
Revenues in Q3 2023 were $214.9 million. On a constant currency basis, Q3 2023 revenues decreased 15.3% versus the prior year period.
- Subscription Revenues in Q3 2023 were $203.5 million. On a constant currency basis, these revenues decreased 9.2% versus the prior year period. Subscription Revenues included $10.0 million of Clinical Subscription Revenues.
- Product Sales and Other in Q3 2023 were $11.4 million. On a constant currency basis, these revenues decreased 61.0% versus the prior year period driven by the continued wind down of the consumer products business.
Gross Profit in Q3 2023 was $141.8 million, compared to $152.4 million in the prior year period. Adjusted gross profit in Q3 2023, which excluded the net impact of $0.4 million of restructuring charges, was $142.2 million. Adjusted gross profit in Q3 2022, which excluded the net impact of $0.0 million of restructuring charges, was $152.4 million.
- Gross Margin in Q3 2023 was 66.0%, as compared to 61.0% in the prior year period. Adjusted gross margin in Q3 2023 was 66.2%, up from an adjusted gross margin of 61.0% in the prior year period, primarily driven by actions to reduce the fixed cost base within the Workshops + Digital business and a revenue mix shift to the Company's higher margin Digital business.
Operating Income in Q3 2023 was $30.6 million, compared to operating loss of $254.5 million in the prior year period. Adjusted operating income in Q3 2023, which excluded the net impact of $6.0 million of restructuring charges, was $36.6 million. Adjusted operating income in Q3 2022, which excluded the impact of non-cash intangible impairment charges totaling $312.7 million and the net impact of $3.7 million of restructuring charges, was $61.9 million.
Income Tax Benefit in Q3 2023 was $38.4 million, which reflected the impact of an unusually high negative annual effective tax rate driven by a valuation allowance and small pretax loss reflected in the Company's full year fiscal 2023 guidance. In the prior year period, income tax was a benefit of $70.7 million.
Net Income in Q3 2023 was $43.7 million compared to net loss of $206.0 million in the prior year period.
Diluted earnings per share in Q3 2023 was $0.54 compared to diluted net loss per share of $2.93 in the prior year period.
- Certain items affect year-over-year comparability.
  - Q3 2023 diluted earnings per share incorporated the net positive impact of $0.48 per diluted share in the aggregate due to the following items:
    - $0.54 per diluted share positive tax impact arising from an unusually high negative annual effective tax rate as a result of a valuation allowance and small pretax loss reflected in the Company's full year fiscal 2023 guidance, mentioned above.
    - $0.06 per diluted share net negative impact of restructuring charges.
  - Q3 2022 diluted net loss per share incorporated the negative impact of $3.38 per diluted share in the aggregate due to the following items:
    - $3.34 per diluted share negative impact of non-cash intangible impairment charges for Franchise Rights Acquired.
    - $0.04 per diluted share net negative impact of restructuring charges.

Other Items

Cash balance as of September 30, 2023 was $107.5 million. On that same date, the Company had no outstanding borrowings under its revolving credit facility.
2023 Restructuring Plan: In connection with the previously announced 2023 restructuring plan, the Company recorded aggregate restructuring charges of $6.2 million in Q3 2023. The Company anticipates recording restructuring charges of up to $10.0 million in Q4 2023, increasing the Company's estimated range for the 2023 restructuring plan to be between $47.0 million to $54.0 million.

Full Year Fiscal 2023 Guidance

The Company is updating its full year fiscal 2023 guidance:

Revenues are expected to be at the low end of the previously provided range of $890.0 million to $910.0 million.
Operating income is now expected to be in the range of $31.0 million to $43.0 million, compared to the previously provided range of $39.0 million to $51.0 million, due to increased anticipated restructuring charges. Adjusted operating income, which excludes the net impact of restructuring charges and acquisition transaction costs, is still expected to be towards the high end of the previously provided range of $80.0 million to $85.0 million.

Third Quarter 2023 Conference Call and Webcast

The Company has scheduled a conference call today at 4:30 p.m. ET. During the conference call, Sima Sistani, Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter of fiscal 2023 results and answer questions from the investment community.

The live webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, in the Investors section under Presentations and Events. Supplemental investor materials will also be available in the same location prior to the start of the webcast. A replay of the webcast will be available on this site for approximately 90 days.

Statement regarding Non-GAAP Financial Measures

The following provides information regarding non-GAAP financial measures used in this earnings release and today's scheduled conference call:

To supplement the Company's consolidated results presented in accordance with accounting principles generally accepted in the United States ("GAAP"), the Company has disclosed non-GAAP financial measures of operating results that exclude or adjust certain items. Gross profit, gross margin, operating income (loss), operating income (loss) margin, and selling, general and administrative expenses are discussed both as reported (on a GAAP basis) and as adjusted (on a non-GAAP basis), as applicable, with respect to (i) the third quarter of fiscal 2023 to exclude the net impact of (a) charges associated with the Company's previously disclosed 2023 restructuring plan (the "2023 plan") and (b) the reversal of certain of the charges associated with the Company's previously disclosed 2022 restructuring plan (the "2022 plan"); (ii) the first nine months of fiscal 2023 to exclude (a) the net impact of (w) charges associated with the 2023 plan, (x) charges associated with the 2022 plan or the reversal of certain of the charges associated with the 2022 plan, as applicable, (y) charges associated with the Company's previously disclosed 2021 organizational restructuring plan (the "2021 plan") or the reversal of certain of the charges associated with the 2021 plan, as applicable, and (z) the reversal of certain of the charges associated with the Company's previously disclosed 2020 organizational restructuring plan (the "2020 plan") and (b) the impact of certain non-recurring transaction costs in connection with the acquisition of Sequence (as defined below); (iii) the third quarter of fiscal 2022 to exclude (a) the impact of impairment charges for the Company's franchise rights acquired related to its United States, Canada and New Zealand units of account and (b) the net impact of (x) charges associated with the 2022 plan and (y) charges associated with the 2021 plan; and (iv) the first nine months of fiscal 2022 to exclude (a) the impact of impairment charges for the Company's franchise rights acquired related to its United States, Canada and New Zealand units of account and the impairment charge for the Company's goodwill related to its wholly-owned subsidiary Kurbo, Inc. ("Kurbo") and (b) the net impact of (x) charges associated with the 2022 plan, (y) charges associated with the 2021 plan or the reversal of certain of the charges associated with the 2021 plan, as applicable, and (z) the reversal of certain of the charges associated with the 2020 plan. We generally refer to such non-GAAP measures as follows: (i) with respect to the adjustments for the third quarter of fiscal 2023, as excluding or adjusting for the net impact of restructuring charges; (ii) with respect to the adjustments for the first nine months of fiscal 2023, as excluding or adjusting for the net impact of restructuring charges and the impact of acquisition transaction costs; (iii) with respect to the adjustments for the third quarter of fiscal 2022, as excluding or adjusting for the impact of the franchise rights acquired impairments and the net impact of restructuring charges; and (iv) with respect to the adjustments for the first nine months of fiscal 2022, as excluding or adjusting for the impact of franchise rights acquired and goodwill impairments and the net impact of restructuring charges. The Company also presents in the attachments to this release the non-GAAP financial measures earnings before interest, taxes, depreciation, amortization and stock-based compensation ("EBITDAS"); earnings before interest, taxes, depreciation, amortization, stock-based compensation, franchise rights acquired and goodwill impairments, net restructuring charges, and certain non-recurring transaction costs in connection with the acquisition of Sequence ("Adjusted EBITDAS"); total debt less unamortized deferred financing costs, unamortized debt discount and cash on hand (i.e., net debt); and a net debt/Adjusted EBITDAS ratio. Adjusted EBITDAS for the first quarter of fiscal 2023 as presented herein was recast to reflect certain non-recurring transaction costs in connection with the acquisition of Sequence. In addition, the Company presents certain of its financial results on a constant currency basis in addition to GAAP results. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. The Company calculates constant currency by calculating current-year results using prior-year foreign currency exchange rates.

Management believes these non-GAAP financial measures provide useful supplemental information for its and investors' evaluation of the Company's business performance and are useful for period-over-period comparisons of the performance of the Company's business. While management believes that these non-GAAP financial measures are useful in evaluating the Company's business, this information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similarly entitled measures reported by other companies. See "Reconciliation of Non-GAAP Financial Measures" attached to this release and reconciliations, if any, included elsewhere in this release for a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures.

About WW International, Inc.

WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management program. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our program. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.

For more information, contact:

Investors:

Corey Kinger

corey.kinger@ww.com

Media:

Kelsey Merkel

kelsey.merkel@ww.com

This news release and any attachments include "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, in particular, any guidance and any statements about the Company's plans, strategies, objectives, initiatives, roadmap and prospects. The Company generally uses the words "may," "will," "could," "expect," "anticipate," "believe," "estimate," "plan," "intend," "aim" and similar expressions in this news release and any attachments to identify forward-looking statements. The Company bases these forward-looking statements on its current views with respect to future events and financial performance. Actual results could differ materially from those projected in the forward-looking statements. These forward-looking statements are subject to risks, uncertainties and assumptions, including, among other things: the impact of the COVID-19 pandemic on the Company's business and on the consumer environment and markets in which the Company operates; competition from other weight management and wellness industry participants or the development of more effective or more favorably perceived weight management methods; the Company's failure to continue to retain and grow its subscriber base; the Company's ability to continue to develop new, innovative services and products and enhance its existing services and products or the failure of its services, products or brands to continue to appeal to the market, or its ability to successfully expand into new channels of distribution or respond to consumer trends or sentiment; the ability to successfully implement strategic initiatives; the Company's ability to transform its Workshops + Digital business strategy to meet the evolving needs of its members; the effectiveness and efficiency of the Company's advertising and marketing programs, including the strength of the Company's social media presence; the impact on the Company's reputation of actions taken by its franchisees, licensees, suppliers and other partners, including as a result of its acquisition of Weekend Health, Inc., which is doing business as Sequence ("Sequence") (the "Acquisition"); the recognition of asset impairment charges; the loss of key personnel, strategic partners or consultants or failure to effectively manage and motivate the Company's workforce; the Company's chief executive officer transition; the inability to renew certain of the Company's licenses, or the inability to do so on terms that are favorable to the Company; the early termination by the Company of leases; uncertainties related to a downturn in general economic conditions or consumer confidence, including as a result of the existing inflationary environment, the potential impact of political and social unrest and instability in the banking system as a result of several recent bank failures; the Company's ability to successfully make acquisitions or enter into joint ventures or collaborations, including its ability to successfully integrate, operate or realize the anticipated benefits of such businesses, including with respect to Sequence; the seasonal nature of the Company's principal business; the impact of events that discourage or impede people from gathering with others or impede accessing resources; the Company's failure to maintain effective internal control over financial reporting; the impact of the Company's substantial amount of debt, debt service obligations and debt covenants, and its exposure to variable rate indebtedness; the ability to generate sufficient cash to service the Company's debt and satisfy its other liquidity requirements; uncertainties regarding the satisfactory operation of the Company's technology or systems; the impact of data security breaches and other malicious acts or privacy concerns, including the costs of compliance with evolving privacy laws and regulations; the Company's ability to enforce its intellectual property rights both domestically and internationally, as well as the impact of its involvement in any claims related to intellectual property rights; risks and uncertainties associated with the Company's international operations, including regulatory, economic, political, social, intellectual property, and foreign currency risks, which risks may be exacerbated as a result of war and terrorism; the outcomes of litigation or regulatory actions; the impact of existing and future laws and regulations; risks related to the Company's Acquisition, including risks that the Acquisition may not achieve its intended results; risks related to the Company's exposure to extensive and complex healthcare laws and regulations as a result of the Acquisition; the impact that the sale of substantial amounts of the Company's common stock by existing large shareholders, or the perception that such sales could occur, could have on the market price of the Company's common stock; and other risks and uncertainties, including those detailed from time to time in the Company's periodic reports filed with the United States Securities and Exchange Commission (the "SEC") (which are available on the SEC's EDGAR database at www.sec.gov and via the Company's website at corporate.ww.com). You should not put undue reliance on any forward-looking statements. You should understand that many important factors, including those discussed herein, could cause the Company's results to differ materially from those expressed or suggested in any forward-looking statement. Except as required by law, the Company does not undertake any obligation to update or revise these forward-looking statements to reflect new information or events or circumstances that occur after the date of this news release or to reflect the occurrence of unanticipated events or otherwise. Readers are advised to review the Company's filings with the SEC (which are available on the SEC's EDGAR database at www.sec.gov and via the Company's website at corporate.ww.com).

WW INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS AT
(IN THOUSANDS)
UNAUDITED


	September 30,			December 31,
		2023			2022
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	107,498		$	178,326
Receivables (net of allowances: September 30, 2023 - $1,435 and December 31, 2022 - $976)		19,178			24,273
Inventories		10,141			20,528
Prepaid income taxes		53,880			19,447
Prepaid expenses and other current assets		28,092			38,757
TOTAL CURRENT ASSETS		218,789			281,331
Property and equipment, net		22,608			28,229
Operating lease assets		55,414			75,696
Franchise rights acquired		386,168			386,745
Goodwill		244,927			155,998
Other intangible assets, net		66,532			63,306
Deferred income taxes		20,728			22,246
Other noncurrent assets		17,087			14,879
TOTAL ASSETS	$	1,032,253		$	1,028,430
LIABILITIES AND TOTAL DEFICIT
CURRENT LIABILITIES
Portion of operating lease liabilities due within one year	$	9,804		$	17,955
Accounts payable		19,732			18,890
Salaries and wages payable		61,794			72,577
Accrued marketing and advertising		13,645			17,927
Accrued interest		10,969			5,289
Other accrued liabilities		44,569			30,118
Income taxes payable		987			1,646
Deferred revenue		32,445			32,156
TOTAL CURRENT LIABILITIES		193,945			196,558
Long-term debt, net		1,425,419			1,422,284
Long-term operating lease liabilities		56,643			68,099
Deferred income taxes		15,932			25,084		⁽¹⁾
Other		15,481			2,185
TOTAL LIABILITIES		1,707,420			1,714,210		⁽¹⁾

TOTAL DEFICIT
Common stock, $0 par value; 1,000,000 shares authorized; 130,048 shares issued at September 30, 2023 and 122,052 shares issued at December 31, 2022		0			0
Treasury stock, at cost, 51,030 shares at September 30, 2023 and 51,496 shares at December 31, 2022		(3,073,196	)		(3,097,304	)
Retained earnings		2,409,997			2,416,994		⁽¹⁾
Accumulated other comprehensive loss		(11,968	)		(5,470	)
TOTAL DEFICIT		(675,167	)		(685,780	)	⁽¹⁾
TOTAL LIABILITIES AND TOTAL DEFICIT	$	1,032,253		$	1,028,430
___
⁽¹⁾ Certain amounts have been revised at December 31, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company's Form 10-Q filing for the fiscal quarter ended September 30, 2023.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
UNAUDITED


		Three Months Ended
		September 30,			October 1,
			2023			2022
Subscription revenues, net ⁽¹⁾		$	203,496		$	220,746
Product sales and other, net ⁽²⁾			11,375			28,972
	Revenues, net		214,871			249,718
Cost of subscription revenues ⁽³⁾			67,080			73,541
Cost of product sales and other			6,036			23,826
	Cost of revenues		73,116			97,367
	Gross profit		141,755			152,351
Marketing expenses			48,114			35,696
Selling, general and administrative expenses			63,034			58,443
Franchise rights acquired impairments			—			312,741
	Operating income (loss)		30,607			(254,529	)
Interest expense			24,508			20,912
Other expense, net			815			1,344
	Income (loss) before income taxes		5,284			(276,785	)
Benefit from income taxes			(38,447	)		(70,749	)
	Net income (loss)	$	43,731		$	(206,036	)

Earnings (net loss) per share
	Basic	$	0.55		$	(2.93	)
	Diluted	$	0.54		$	(2.93	)

Weighted average common shares outstanding
	Basic		78,979			70,383
	Diluted		80,638			70,383

___
Note: Totals may not sum due to rounding.
⁽¹⁾ Consists of net "Digital Subscription Revenues", net "Workshops + Digital Fees" and net "Clinical Subscription Revenues". "Digital Subscription Revenues" consist of the fees associated with subscriptions for the Company's Digital offerings, which formerly included Digital 360 (as applicable). "Workshops + Digital Fees" consist of the fees associated with the Company's subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops. "Clinical Subscription Revenues" consist of the fees associated with subscriptions for the Company's Clinical offerings.
⁽²⁾ Consists of sales of consumer products via e-commerce, in studios and through the Company's trusted partners, revenues from licensing and publishing, other revenues, and franchise fees with respect to commitment plans and royalties.
⁽³⁾ Consists of cost of revenues and operating expenses for the Company's Digital, Workshops + Digital and Clinical services.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
UNAUDITED


		Nine Months Ended
		September 30,			October 1,
			2023			2022
Subscription revenues, net ⁽¹⁾		$	626,667		$	718,122
Product sales and other, net ⁽²⁾			56,927			98,810
	Revenues, net		683,594			816,932
Cost of subscription revenues ⁽³⁾			233,354			243,710
Cost of product sales and other			45,794			77,811
	Cost of revenues		279,148			321,521
	Gross profit		404,446			495,411
Marketing expenses			187,468			195,123
Selling, general and administrative expenses			188,638			193,320
Franchise rights acquired and goodwill impairments			—			339,161
	Operating income (loss)		28,340			(232,193	)
Interest expense			71,429			58,837
Other (income) expense, net			(36	)		3,303
	Loss before income taxes		(43,053	)		(294,333	)
Benefit from income taxes			(18,933	)		(73,246	)	⁽⁴⁾
	Net loss	$	(24,120	)	$	(221,087	)	⁽⁴⁾

Net loss per share
	Basic	$	(0.32	)	$	(3.15	)	⁽⁴⁾
	Diluted	$	(0.32	)	$	(3.15	)	⁽⁴⁾

Weighted average common shares outstanding
	Basic		75,861			70,258
	Diluted		75,861			70,258

___
Note: Totals may not sum due to rounding.
⁽¹⁾ Consists of net "Digital Subscription Revenues", net "Workshops + Digital Fees" and net "Clinical Subscription Revenues". "Digital Subscription Revenues" consist of the fees associated with subscriptions for the Company's Digital offerings, which formerly included Digital 360 (as applicable). "Workshops + Digital Fees" consist of the fees associated with the Company's subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops. "Clinical Subscription Revenues" consist of the fees associated with subscriptions for the Company's Clinical offerings.
⁽²⁾ Consists of sales of consumer products via e-commerce, in studios and through the Company's trusted partners, revenues from licensing and publishing, other revenues, and franchise fees with respect to commitment plans and royalties.
⁽³⁾ Consists of cost of revenues and operating expenses for the Company's Digital, Workshops + Digital and Clinical services.
⁽⁴⁾ Certain amounts have been revised for the nine months ended October 1, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company's Form 10-Q filing for the fiscal quarter ended September 30, 2023.

	WW INTERNATIONAL, INC. AND SUBSIDIARIES
	CONSOLIDATED STATEMENTS OF CASH FLOWS
	(IN THOUSANDS)
	UNAUDITED


		Nine Months Ended
		September 30,			October 1,
			2023			2022
Operating activities:
	Net loss	$	(24,120	)	$	(221,087	)	⁽¹⁾
	Adjustments to reconcile net loss to cash (used for) provided by operating activities:
	Depreciation and amortization		39,805			33,371
	Amortization of deferred financing costs and debt discount		3,763			3,763
	Impairment of franchise rights acquired and goodwill		—			339,161
	Impairment of intangible and long-lived assets		197			2,088
	Share-based compensation expense		12,838			10,362
	Deferred tax benefit		(7,449	)		(107,879	)
	Allowance for doubtful accounts		407			54
	Reserve for inventory obsolescence		1,897			4,712
	Foreign currency exchange rate (gain) loss		(31	)		3,562
	Changes in cash due to:
	Receivables		9,117			(9,760	)
	Inventories		9,009			(725	)
	Prepaid expenses		(27,301	)		17,613
	Accounts payable		1,221			(3,634	)
	Accrued liabilities		(17,010	)		15,390
	Deferred revenue		309			(3,576	)
	Other long term assets and liabilities, net		(2,701	)		(4,662	)
	Income taxes		(1,104	)		1,793		⁽¹⁾
	Cash (used for) provided by operating activities		(1,153	)		80,546
Investing activities:
	Capital expenditures		(2,143	)		(1,756	)
	Capitalized software expenditures		(26,190	)		(27,584	)
	Cash paid for acquisitions, net of cash acquired		(38,362	)		(4,350	)
	Other items, net		(14	)		(29	)
	Cash used for investing activities		(66,709	)		(33,719	)
Financing activities:
	Taxes paid related to net share settlement of equity awards		(1,417	)		(1,938	)
	Proceeds from stock options exercised		710			—
	Cash paid for acquisitions		(1,178	)		(113	)
	Other items, net		(43	)		(86	)
	Cash used for financing activities		(1,928	)		(2,137	)
Effect of exchange rate changes on cash and cash equivalents			(1,038	)		(10,193	)
Net (decrease) increase in cash and cash equivalents			(70,828	)		34,497
Cash and cash equivalents, beginning of period			178,326			153,794
Cash and cash equivalents, end of period		$	107,498		$	188,291

___
⁽¹⁾ Certain amounts have been revised for the nine months ended October 1, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company's Form 10-Q filing for the fiscal quarter ended September 30, 2023.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
OPERATIONAL STATISTICS
(IN THOUSANDS, EXCEPT PERCENTAGES)
UNAUDITED


	Three Months Ended
	September 30,	October 1,	Variance
	2023	2022	Variance

Digital Paid Weeks⁽¹⁾
North America	27,605	26,274	5.1%
International	15,205	15,325	(0.8%)
Total Digital Paid Weeks	42,810	41,599	2.9%

Workshops + Digital Paid Weeks ⁽¹⁾
North America	6,882	7,753	(11.2%)
International	2,251	2,581	(12.8%)
Total Workshops + Digital Paid Weeks	9,133	10,334	(11.6%)

Clinical Paid Weeks ⁽¹⁾
North America	534	—	N/A
International	—	—	—
Total Clinical Paid Weeks	534	—	N/A

Total Paid Weeks ⁽¹⁾
North America	35,021	34,028	2.9%
International	17,457	17,905	(2.5%)
Total Paid Weeks	52,478	51,933	1.0%

End of Period Digital Subscribers ⁽²⁾
North America	2,112	1,908	10.7%
International	1,172	1,138	3.0%
Total End of Period Digital Subscribers	3,284	3,046	7.8%

End of Period Workshops + Digital Subscribers ⁽²⁾
North America	518	555	(6.7%)
International	175	192	(9.2%)
Total End of Period Workshops + Digital Subscribers	693	748	(7.3%)

End of Period Clinical Subscribers ⁽²⁾
North America	45	—	N/A
International	—	—	—
Total End of Period Clinical Subscribers	45	—	N/A

Total End of Period Subscribers ⁽²⁾
North America	2,676	2,464	8.6%
International	1,346	1,330	1.2%
Total End of Period Subscribers	4,022	3,794	6.0%

___
Note: Totals may not sum due to rounding.
⁽¹⁾ The "Paid Weeks" metric reports paid weeks by WW customers in Company-owned operations for a given period as follows: (i) "Digital Paid Weeks" is the total paid subscription weeks for the Company's digital subscription products, which formerly included Digital 360 (as applicable); (ii) "Workshops + Digital Paid Weeks" is the sum of total paid commitment plan weeks which include workshops and digital offerings and formerly included total "pay-as-you-go" weeks; (iii) "Clinical Paid Weeks" is the total paid subscription weeks for the Company's Clinical subscription products; and (iv) "Total Paid Weeks" is the sum of Digital Paid Weeks, Workshops + Digital Paid Weeks and Clinical Paid Weeks.
⁽²⁾ The "End of Period Subscribers" metric reports WW subscribers in Company-owned operations at a given period end as follows: (i) "End of Period Digital Subscribers" is the total number of Digital, including former Digital 360 (as applicable), subscribers; (ii) "End of Period Workshops + Digital Subscribers" is the total number of commitment plan subscribers that have access to combined workshops and digital offerings; (iii) "End of Period Clinical Subscribers" is the total number of Clinical subscribers; and (iv) "End of Period Subscribers" is the sum of End of Period Digital Subscribers, End of Period Workshops + Digital Subscribers and End of Period Clinical Subscribers.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
OPERATIONAL STATISTICS
(IN THOUSANDS, EXCEPT PERCENTAGES)
UNAUDITED


	Nine Months Ended
	September 30,	October 1,	Variance
	2023	2022	Variance

Digital Paid Weeks⁽¹⁾
North America	81,392	87,743	(7.2%)
International	45,465	50,312	(9.6%)
Total Digital Paid Weeks	126,858	138,055	(8.1%)

Workshops + Digital Paid Weeks ⁽¹⁾
North America	21,914	22,724	(3.6%)
International	7,126	7,547	(5.6%)
Total Workshops + Digital Paid Weeks	29,039	30,271	(4.1%)

Clinical Paid Weeks ⁽¹⁾
North America	889	—	N/A
International	—	—	—
Total Clinical Paid Weeks	889	—	N/A

Total Paid Weeks ⁽¹⁾
North America	104,195	110,466	(5.7%)
International	52,591	57,860	(9.1%)
Total Paid Weeks	156,786	168,326	(6.9%)

End of Period Digital Subscribers ⁽²⁾
North America	2,112	1,908	10.7%
International	1,172	1,138	3.0%
Total End of Period Digital Subscribers	3,284	3,046	7.8%

End of Period Workshops + Digital Subscribers ⁽²⁾
North America	518	555	(6.7%)
International	175	192	(9.2%)
Total End of Period Workshops + Digital Subscribers	693	748	(7.3%)

End of Period Clinical Subscribers ⁽²⁾
North America	45	—	N/A
International	—	—	—
Total End of Period Clinical Subscribers	45	—	N/A

Total End of Period Subscribers ⁽²⁾
North America	2,676	2,464	8.6%
International	1,346	1,330	1.2%
Total End of Period Subscribers	4,022	3,794	6.0%

___
Note: Totals may not sum due to rounding.
⁽¹⁾ The "Paid Weeks" metric reports paid weeks by WW customers in Company-owned operations for a given period as follows: (i) "Digital Paid Weeks" is the total paid subscription weeks for the Company's digital subscription products, which formerly included Digital 360 (as applicable); (ii) "Workshops + Digital Paid Weeks" is the sum of total paid commitment plan weeks which include workshops and digital offerings and formerly included total "pay-as-you-go" weeks; (iii) "Clinical Paid Weeks" is the total paid subscription weeks for the Company's Clinical subscription products; and (iv) "Total Paid Weeks" is the sum of Digital Paid Weeks, Workshops + Digital Paid Weeks and Clinical Paid Weeks.
⁽²⁾ The "End of Period Subscribers" metric reports WW subscribers in Company-owned operations at a given period end as follows: (i) "End of Period Digital Subscribers" is the total number of Digital, including former Digital 360 (as applicable), subscribers; (ii) "End of Period Workshops + Digital Subscribers" is the total number of commitment plan subscribers that have access to combined workshops and digital offerings; (iii) "End of Period Clinical Subscribers" is the total number of Clinical subscribers; and (iv) "End of Period Subscribers" is the sum of End of Period Digital Subscribers, End of Period Workshops + Digital Subscribers and End of Period Clinical Subscribers.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(IN THOUSANDS, EXCEPT PERCENTAGES)
UNAUDITED


										Q3 2023 Variance
												2023
												Constant
	Q3 2023							Q3 2022		2023		Currency
			Currency			Constant				vs		vs
	GAAP		Adjustment			Currency		GAAP		2022		2022

Selected Financial Data
Consolidated Company Revenues	$	214,871	$	(3,246	)	$	211,625	$	249,718	(14.0	%)	(15.3	%)
Consolidated Digital Subscription Revenues ⁽¹⁾	$	140,889	$	(2,671	)	$	138,218	$	155,881	(9.6	%)	(11.3	%)
Consolidated Workshops + Digital Fees ⁽²⁾	$	52,618	$	(491	)	$	52,127	$	64,865	(18.9	%)	(19.6	%)
Consolidated Clinical Subscription Revenues ⁽³⁾	$	9,989	$	—		$	9,989	$	—	N/A		N/A
Consolidated Subscription Revenues ⁽⁴⁾	$	203,496	$	(3,161	)	$	200,335	$	220,746	(7.8	%)	(9.2	%)
Consolidated Product Sales and Other ⁽⁵⁾	$	11,375	$	(85	)	$	11,290	$	28,972	(60.7	%)	(61.0	%)

North America
Digital Subscription Revenues⁽¹⁾	$	92,437	$	151		$	92,588	$	102,735	(10.0	%)	(9.9	%)
Workshops + Digital Fees ⁽²⁾	$	42,867	$	54		$	42,921	$	52,113	(17.7	%)	(17.6	%)
Clinical Subscription Revenues⁽³⁾	$	9,989	$	—		$	9,989	$	—	N/A		N/A
Subscription Revenues ⁽⁴⁾	$	145,293	$	205		$	145,498	$	154,848	(6.2	%)	(6.0	%)
Product Sales and Other⁽⁵⁾	$	9,394	$	5		$	9,399	$	21,621	(56.6	%)	(56.5	%)
Total Revenues	$	154,687	$	210		$	154,897	$	176,469	(12.3	%)	(12.2	%)

International
Digital Subscription Revenues⁽¹⁾	$	48,452	$	(2,821	)	$	45,631	$	53,146	(8.8	%)	(14.1	%)
Workshops + Digital Fees ⁽²⁾	$	9,751	$	(545	)	$	9,206	$	12,752	(23.5	%)	(27.8	%)
Clinical Subscription Revenues⁽³⁾	$	—	$	—		$	—	$	—	N/A		N/A
Subscription Revenues ⁽⁴⁾	$	58,203	$	(3,366	)	$	54,837	$	65,898	(11.7	%)	(16.8	%)
Product Sales and Other⁽⁵⁾	$	1,981	$	(90	)	$	1,891	$	7,351	(73.1	%)	(74.3	%)
Total Revenues	$	60,184	$	(3,456	)	$	56,728	$	73,249	(17.8	%)	(22.6	%)

___
Note: Totals may not sum due to rounding.
⁽¹⁾ "Digital Subscription Revenues" consist of the fees associated with subscriptions for the Company's Digital offerings, which formerly included Digital 360 (as applicable).
⁽²⁾ "Workshops + Digital Fees" consist of the fees associated with the Company's subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops.
⁽³⁾ "Clinical Subscription Revenues" consist of the fees associated with subscriptions for the Company's Clinical offerings.
⁽⁴⁾ "Subscription Revenues" equal "Digital Subscription Revenues" plus "Workshops + Digital Fees" plus "Clinical Subscription Revenues".
⁽⁵⁾ "Product Sales and Other" are sales of consumer products via e-commerce, in studios and through the Company's trusted partners, revenues from licensing and publishing, other revenues, and, in the case of the consolidated financial results and North America reportable segment, franchise fees with respect to commitment plans and royalties.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(IN THOUSANDS, EXCEPT PERCENTAGES)
UNAUDITED


										YTD 2023 Variance
												2023
												Constant
	YTD 2023							YTD 2022		2023		Currency
			Currency			Constant				vs		vs
	GAAP		Adjustment			Currency		GAAP		2022		2022

Selected Financial Data
Consolidated Company Revenues	$	683,594	$	1,696		$	685,290	$	816,932	(16.3	%)	(16.1	%)
Consolidated Digital Subscription Revenues ⁽¹⁾	$	437,613	$	610		$	438,223	$	521,582	(16.1	%)	(16.0	%)
Consolidated Workshops + Digital Fees ⁽²⁾	$	171,473	$	601		$	172,074	$	196,540	(12.8	%)	(12.4	%)
Consolidated Clinical Subscription Revenues ⁽³⁾	$	17,581	$	—		$	17,581	$	—	N/A		N/A
Consolidated Subscription Revenues ⁽⁴⁾	$	626,667	$	1,211		$	627,878	$	718,122	(12.7	%)	(12.6	%)
Consolidated Product Sales and Other ⁽⁵⁾	$	56,927	$	485		$	57,412	$	98,810	(42.4	%)	(41.9	%)

North America
Digital Subscription Revenues⁽¹⁾	$	285,655	$	878		$	286,533	$	342,489	(16.6	%)	(16.3	%)
Workshops + Digital Fees ⁽²⁾	$	138,639	$	326		$	138,965	$	155,558	(10.9	%)	(10.7	%)
Clinical Subscription Revenues⁽³⁾	$	17,581	$	—		$	17,581	$	—	N/A		N/A
Subscription Revenues ⁽⁴⁾	$	441,875	$	1,204		$	443,079	$	498,047	(11.3	%)	(11.0	%)
Product Sales and Other⁽⁵⁾	$	46,025	$	116		$	46,141	$	71,478	(35.6	%)	(35.4	%)
Total Revenues	$	487,900	$	1,320		$	489,220	$	569,525	(14.3	%)	(14.1	%)

International
Digital Subscription Revenues⁽¹⁾	$	151,958	$	(268	)	$	151,690	$	179,093	(15.2	%)	(15.3	%)
Workshops + Digital Fees ⁽²⁾	$	32,834	$	276		$	33,110	$	40,982	(19.9	%)	(19.2	%)
Clinical Subscription Revenues⁽³⁾	$	—	$	—		$	—	$	—	N/A		N/A
Subscription Revenues ⁽⁴⁾	$	184,792	$	7		$	184,799	$	220,075	(16.0	%)	(16.0	%)
Product Sales and Other⁽⁵⁾	$	10,902	$	369		$	11,271	$	27,332	(60.1	%)	(58.8	%)
Total Revenues	$	195,694	$	376		$	196,070	$	247,407	(20.9	%)	(20.8	%)

___
Note: Totals may not sum due to rounding.
⁽¹⁾ "Digital Subscription Revenues" consist of the fees associated with subscriptions for the Company's Digital offerings, which formerly included Digital 360 (as applicable).
⁽²⁾ "Workshops + Digital Fees" consist of the fees associated with the Company's subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops.
⁽³⁾ "Clinical Subscription Revenues" consist of the fees associated with subscriptions for the Company's Clinical offerings.
⁽⁴⁾ "Subscription Revenues" equal "Digital Subscription Revenues" plus "Workshops + Digital Fees" plus "Clinical Subscription Revenues".
⁽⁵⁾ "Product Sales and Other" are sales of consumer products via e-commerce, in studios and through the Company's trusted partners, revenues from licensing and publishing, other revenues, and, in the case of the consolidated financial results and North America reportable segment, franchise fees with respect to commitment plans and royalties.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(IN THOUSANDS, EXCEPT PERCENTAGES)
UNAUDITED


																									Q3 2023 Variance
																													2023 Constant Currency
																											2023				2023
	Q3 2023															Q3 2022											Adjusted				Adjusted
														Adjusted											2023		vs		2023		vs
									Currency			Constant		Constant											vs		2022		vs		2022
	GAAP		Adjustment				Adjusted		Adjustment			Currency		Currency		GAAP			Adjustment				Adjusted		2022		Adjusted		2022		Adjusted

Selected Financial Data
Gross Profit	$	141,755	$	398		⁽¹⁾	$	142,153	$	(2,672	)	$	139,083	$	139,481	$	152,351		$	6		⁽⁴⁾	$	152,357	(7.0%	)	(6.7%	)	(8.7%	)	(8.5%)
Gross Margin		66.0%						66.2%					65.7%		65.9%		61.0%							61.0%

Selling, General and Administrative Expenses	$	63,034	$	(5,577	)	⁽²⁾	$	57,457	$	(485	)	$	62,549	$	56,972	$	58,443		$	(3,654	)	⁽⁵⁾	$	54,789	7.9%		4.9%		7.0%		4.0%

Operating Income (Loss)	$	30,607	$	5,975		⁽³⁾	$	36,582	$	(1,598	)	$	29,009	$	34,984	$	(254,529	)	$	316,401		⁽⁶⁾	$	61,872	112.0%		(40.9%	)	111.4%		(43.5%)
Operating Income (Loss) Margin		14.2%						17.0%					13.7%		16.5%		(101.9%	)						24.8%

___
Note: Totals may not sum due to rounding.
⁽¹⁾Excludes the net impact of $444 of charges associated with the Company's previously disclosed 2023 restructuring plan and the reversal of $46 of charges associated with the Company's previously disclosed 2022 restructuring plan.
⁽²⁾Excludes the net impact of $5,743 of charges associated with the Company's previously disclosed 2023 restructuring plan and the reversal of $166 of charges associated with the Company's previously disclosed 2022 restructuring plan.
⁽³⁾Excludes the net impact of (x) $444 of charges and $5,743 of charges associated with the Company's previously disclosed 2023 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, and (y) the reversal of $46 of charges and the reversal of $166 of charges associated with the Company's previously disclosed 2022 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively.
⁽⁴⁾Excludes the net impact of the reversal of $98 of charges associated with the Company's previously disclosed 2022 restructuring plan and $104 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan.
⁽⁵⁾Excludes the net impact of $3,655 of charges associated with the Company's previously disclosed 2022 restructuring plan and the reversal of $1 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan.
⁽⁶⁾Excludes (i) the impact of impairment charges of the Company's franchise rights acquired of $298,291, $13,312 and $1,138 related to its United States, Canada and New Zealand operations, respectively and (ii) the net impact of (x) the reversal of $98 of charges and $3,655 of charges associated with the Company's previously disclosed 2022 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, and (y) $104 of charges and the reversal of $1 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively.

	WW INTERNATIONAL, INC. AND SUBSIDIARIES
	RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
	(IN THOUSANDS, EXCEPT PERCENTAGES)
	UNAUDITED


																										YTD 2023 Variance
																														2023 Constant Currency
																												2023				2023
		YTD 2023															YTD 2022											Adjusted				Adjusted
															Adjusted											2023		vs		2023		vs
										Currency			Constant		Constant											vs		2022		vs		2022
		GAAP		Adjustment				Adjusted		Adjustment			Currency		Currency		GAAP			Adjustment				Adjusted		2022		Adjusted		2022		Adjusted

Selected Financial Data
Gross Profit		$	404,446	$	19,675		⁽¹⁾	$	424,121	$	556		$	405,002	$	424,676	$	495,411		$	3,853		⁽⁴⁾	$	499,264	(18.4%	)	(15.1%	)	(18.2%	)	(14.9%)
Gross Margin			59.2%						62.0%					59.1%		62.0%		60.6%							61.1%

Selling, General and Administrative Expenses		$	188,638	$	(20,215	)	⁽²⁾	$	168,423	$	376		$	189,014	$	168,800	$	193,320		$	(18,507	)	⁽⁵⁾	$	174,813	(2.4%	)	(3.7%	)	(2.2%	)	(3.4%)

Operating Income (Loss)		$	28,340	$	39,890		⁽³⁾	$	68,230	$	(1,140	)	$	27,200	$	67,089	$	(232,193	)	$	361,521		⁽⁶⁾	$	129,328	112.2%		(47.2%	)	111.7%		(48.1%)
Operating Income (Loss) Margin			4.1%						10.0%					4.0%		9.8%		(28.4%	)						15.8%

___
Note: Totals may not sum due to rounding.
⁽¹⁾Excludes the net impact of $19,869 of charges associated with the Company's previously disclosed 2023 restructuring plan, the reversal of $269 of charges associated with the Company's previously disclosed 2022 restructuring plan, $96 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan and the reversal of $21 of charges associated with the Company's previously disclosed 2020 organizational restructuring plan.
⁽²⁾Excludes (i) the net impact of $10,734 of charges associated with the Company's previously disclosed 2023 restructuring plan, $915 of charges associated with the Company's previously disclosed 2022 restructuring plan and the reversal of $39 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan, and (ii) the impact of $8,605 of acquisition transaction costs.
⁽³⁾Excludes (i) the net impact of (w) $19,869 of charges and $10,734 of charges associated with the Company's previously disclosed 2023 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, (x) the reversal of $269 of charges and $915 of charges associated with the Company's previously disclosed 2022 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, (y) $96 of charges and the reversal of $39 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, and (z) the reversal of $21 of charges associated with the Company's previously disclosed 2020 organizational restructuring plan recorded to cost of subscription revenues, and (ii) the impact of $8,605 of acquisition transaction costs recorded to selling, general and administrative expenses.
⁽⁴⁾Excludes the net impact of $4,400 of charges associated with the Company's previously disclosed 2022 restructuring plan, the reversal of $431 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan and the reversal of $116 of charges associated with the Company's previously disclosed 2020 organizational restructuring plan.
⁽⁵⁾Excludes the impact of $18,273 of charges associated with the Company's previously disclosed 2022 restructuring plan and $234 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan.
⁽⁶⁾Excludes (i) the impact of impairment charges of the Company's franchise rights acquired of $298,291, $37,797 and $1,972 related to its United States, Canada and New Zealand operations, respectively, and an impairment charge of the Company's goodwill related to its Kurbo operations of $1,101 and (ii) the net impact of (w) $4,400 of charges and $18,273 of charges associated with the Company's previously disclosed 2022 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, (x) the reversal of $431 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan recorded to cost of subscription revenues, (y) $234 of charges associated with the Company's previously disclosed 2021 organizational restructuring plan recorded to selling, general and administrative expenses and (z) the reversal of $116 of charges associated with the Company's previously disclosed 2020 organizational restructuring plan recorded to cost of subscription revenues.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(IN THOUSANDS)
UNAUDITED


			Three Months Ended							Nine Months Ended
		September 30,			October 1,				September 30,			October 1,
		2023			2022				2023			2022

	Net Income (Loss)	$	43,731		$	(206,036	)		$	(24,120	)	$	(221,087	)	⁽¹⁾
	Interest		24,508			20,912				71,429			58,837
	Taxes		(38,447	)		(70,749	)			(18,933	)		(73,246	)	⁽¹⁾
	Depreciation and Amortization		13,428			10,544				35,633			31,941
	Stock-based Compensation		3,225			3,376				8,956			10,362
	EBITDAS	$	46,445		$	(241,953	)		$	72,965		$	(193,193	)

	Franchise Rights Acquired and Goodwill Impairments		—			312,741		⁽²⁾		—			339,161		⁽³⁾
	2023 Plan Restructuring Charges ⁽⁴⁾		6,187			—				30,603			—
	2022 Plan Restructuring Charges ⁽⁵⁾		(212	)		3,557				646			22,674
	2021 Plan Restructuring Charges ⁽⁶⁾		—			103				57			(198	)
	2020 Plan Restructuring Charges ⁽⁷⁾		—			—				(21	)		(116	)
	Acquisition Transaction Costs ⁽⁸⁾		—			—				8,605			—
	Adjusted EBITDAS	$	52,420		$	74,448			$	112,855		$	168,328

___
Note: Totals may not sum due to rounding.
⁽¹⁾Certain amounts have been revised for the nine months ended October 1, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company's Form 10-Q filing for the fiscal quarter ended September 30, 2023.
⁽²⁾Impairment charges of the Company's franchise rights acquired of $298,291, $13,312 and $1,138 related to its United States, Canada and New Zealand operations, respectively.
⁽³⁾Impairment charges of the Company's franchise rights acquired of $298,291, $37,797 and $1,972 related to its United States, Canada and New Zealand operations, respectively, and an impairment charge of the Company's goodwill related to its Kurbo operations of $1,101.
⁽⁴⁾Charges associated with the Company's previously disclosed 2023 restructuring plan.
⁽⁵⁾The reversal of charges or charges, as applicable, associated with the Company's previously disclosed 2022 restructuring plan.
⁽⁶⁾Charges or the reversal of charges, as applicable, associated with the Company's previously disclosed 2021 organizational restructuring plan.
⁽⁷⁾The reversal of charges associated with the Company's previously disclosed 2020 organizational restructuring plan.
⁽⁸⁾Certain non-recurring transaction costs in connection with the Company's acquisition of Sequence.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(IN THOUSANDS, EXCEPT RATIOS)
UNAUDITED


															Trailing Twelve
		Q4 2022				Q1 2023			Q2 2023			Q3 2023			Months
	Net Debt to Adjusted EBITDAS

	Net (Loss) Income	$	(35,780	)	⁽¹⁾	$	(118,679	)	$	50,828		$	43,731		$	(59,900	)
	Interest		22,304				22,846			24,075			24,508			93,733
	Taxes		(36,689	)	⁽¹⁾		67,580			(48,066	)		(38,447	)		(55,622	)
	Depreciation and Amortization		10,407				10,273			11,932			13,428			46,040
	Stock-based Compensation		2,590				2,669			3,063			3,225			11,547
	EBITDAS	$	(37,168	)	⁽¹⁾	$	(15,311	)	$	41,832		$	46,445		$	35,798

	Franchise Rights Acquired and Goodwill Impairments		57,566		⁽²⁾		—			—			—			57,566
	2023 Plan Restructuring Charges ⁽³⁾		13,608				22,632			1,784			6,187			44,211
	2022 Plan Restructuring Charges ⁽⁴⁾		4,507				40			818			(212	)		5,153
	2021 Plan Restructuring Charges ⁽⁵⁾		(142	)			(7	)		64			—			(85	)
	2020 Plan Restructuring Charges ⁽⁶⁾		(621	)			(5	)		(16	)		—			(642	)
	Acquisition Transaction Costs ⁽⁷⁾		—				3,719			4,886			—			8,605
	Adjusted EBITDAS	$	37,750		⁽¹⁾	$	11,068		$	49,368		$	52,420		$	150,606

	Total Debt														$	1,425,419
	Less: Cash															107,498
	Net Debt														$	1,317,921

	Total Debt to Net Loss															(23.8	)	X
	Net Debt to Adjusted EBITDAS															8.8		X

___
Note: Totals may not sum due to rounding.
⁽¹⁾Certain amounts have been revised for Q4 2022 to correct immaterial errors related primarily to certain tax matters, which will be more fully described in the Company's Form 10-Q filing for the fiscal quarter ended September 30, 2023.
⁽²⁾Impairment charges of the Company's franchise rights acquired of $25,739, $19,657, $8,275 and $1,872 related to its United States, Canada, United Kingdom and Australia units of account, respectively, and an impairment charge of the Company's goodwill related to its Republic of Ireland reporting unit of $2,023.
⁽³⁾Charges associated with the Company's previously disclosed 2023 restructuring plan.
⁽⁴⁾Charges or the reversal of charges, as applicable, associated with the Company's previously disclosed 2022 restructuring plan.
⁽⁵⁾The reversal of charges or charges, as applicable, associated with the Company's previously disclosed 2021 organizational restructuring plan.
⁽⁶⁾The reversal of charges associated with the Company's previously disclosed 2020 organizational restructuring plan.
⁽⁷⁾Certain non-recurring transaction costs in connection with the Company's acquisition of Sequence, which includes $3,719 recast for Q1 2023.

WW INTERNATIONAL, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(IN MILLIONS)
UNAUDITED


		Full Year 2023
		Operating Income Guidance Reconciliation

	Operating Income	$31.0 - $43.0
	Net Restructuring Charges ⁽¹⁾	$(40.0) - $(33.0)
	Acquisition Transaction Costs ⁽²⁾	$(8.6)
	Adjusted Operating Income	$80.0 - $85.0

⁽¹⁾Reflects the remaining net restructuring charges incurred and expected to be incurred in fiscal 2023 related to the Company's previously disclosed 2023 restructuring plan, 2022 restructuring plan, 2021 organizational restructuring plan and 2020 organizational restructuring plan.
⁽²⁾Reflects certain non-recurring transaction costs in connection with the Company's acquisition of Sequence, which includes $3.7 million recast for the first quarter of fiscal 2023.

WW International, Inc. Announces Third Quarter 2023 Results